JA - Med.Surg Glucose Testing Meters - Q0650.pdf

VHAPM Part 813.5 Simplified Acquisition Procedures for Certain Commercial Items Attachment 1: Request for Sole Source Justification Template >SAT $7M under FAR13.5

PM Part 813.5 SAP for Certain Commercial Items Page 2 of 4 Original Date: 08/30/17 Revision 02 Date: 08/04/2020

( ) National Security ( ) Public Interest

Demonstration that the Contractor’s Unique Qualifications or Nature of the Acquisition Requires the Use of the Authority Cited Above (applicability of authority): Products have been prescribed for patients by VA Physicians. Pharmacy employees do not have the training and/or authority to countermand physician orders. “Brand Specific” products are the same thing as “dispense as written” on a physician’s prescription. No National Drug Code (NDC) substitutions are permitted. In the VA, Pharmacy Benefits Management (PBM) has determined that CMOP IDs in the National Drug File (NDF) will most always identify “brand specific” products in the “VA PRINT NAME.” This is not always inclusive where a particular NDC has been determined to be “formulation specific” by clinical evaluation performed by the PBM or in the case where only one product in the marketplace has been identified to contain the specific ingredients to match the product code.

Description of Efforts Made to ensure that offers are solicited from as many potential sources as deemed practicable: A synopsis of this requirement was posted to Beta.SAM.gov and the RFQ will be posted as an Other than Full and Open solicitation. Only qualified vendors will be able to submit quotes due to Gray Market/Name Brand only requirements.

Determination by the CO that the Anticipated Cost to the Government will be Fair and Reasonable: The anticipated cost will be fair and reasonable based off competition or the IGCE

8. Description of the Market Research Conducted and the Results, or a Statement of the Reasons Market Research Was Not Conducted: As described in Section 6 above, market research, in accordance with FAR Part 10, was conducted by synopsis of the proposed acquisition, advising industry of the pending acquisition and soliciting inquiries from interested parties; however, non manufacturer requirements apply and the VIP database search concluded there are no known SDVOSB or VOSB manufacturers of the above referenced MedSurg items for NAICS code 325413.

Therefore, the “Rule of Two” cannot be met and no set aside solicitation is feasible.

9. Any Other Facts Supporting the Use of Other than Full and Open Competition: This will be an Other than Full and Open RFQ due to Gray Market/Name Brand only requirements.

10. Listing of Sources that Expressed, in Writing, an Interest in the Acquisition: Qualified small business vendors tend to vary from procurement to procurement.

11. A Statement of the Actions, if any, the Agency May Take to Remove or Overcome any Barriers to Competition before Making subsequent acquisitions for the supplies or services required:

No action is being taken at this time due to the fact that no NDC substitutions are permitted based on physician’s specific orders.

Ralph R. Crum 547284 Digitally signed by Ralph R. Crum 547284 Date: 2020.08.27 10:46:11 -05'00'

James D. Justus 1030208

Digitally signed by James D.

Justus 1030208 Date: 2020.09.04 13:23:54 -05'00'

SCOTT R FISCUS 381888 Digitally signed by SCOTT R FISCUS 381888 Date: 2020.09.04 14:52:08 -05'00'

09/08/2020

TERRY L.

SPITZMILLER

394683

Digitally signed by TERRY

L. SPITZMILLER 394683

Date: 2020.09.08 17:30:52 -05'00'